caio888
I have given up trying to understand why many have sold this stock over the past year considering the amount of information and direction provided by the company. The only thing I can really ascertain is that those who sold never knew what they owned to begin with. If you look at the numerous incremental changes made by Gilles Gagnon to improve Ceapro's opportunities, you really have to wonder why anyone would sell the stock. I suppose that you have many who have been "living in the past" and can't get around the cratering of the stock after the fall of 2016.
Regardless, I was a shareholder back then as I am now. I watched the stock go up, up and up, traded it around but always had the core position. I was not happy to seen it unravel but by the time I found out why it had tanked, I felt it was too late to sell.
As each year has gone by since 2016, Gilles Gagnon has actually created more value for the company but the share price continued to sink. The BNN pumpers and dumpers were the sole reason for the cratering of the stock even though all of them profited greatly. Will they be back? I hope not and seriously doubt it, I would rather have some institutions behind the stock that are investors rather than pump & dumpers like the BNN hucksters.
As far as the buyers of this past week or so go, I suspect that many are now feeling better about speculating about what the future holds for the company. Ceapro has been generating cash and is now debt free. They do not need to raise cash at this time, they have everything under control and they are in control of their future. The company has spent much time in the US over the past few years trying to get their story out. We have seen some increased buying out of the US, hopefully, we will see that continue. I believe that it is a harbinger of things to come. If you really look into the depth of this company, it is a very attractive opportunity for some spectacular gains. If you look at the recent stock price move by SONA, you can really see what Ceapro may be in store for with their recent YBG discovery related to lung fibrosis. If Ceapro is successful in this endeavor, look out.
I have been saying the same things about Ceapro for years on Stockhouse, I post under Oats. I am trying to have my alias on this board changed to Oats but no such luck so far. |
